P1234: A PROGNOSTIC MODEL BASED ON GENE EXPRESSION PARAMETERS PREDICTS A BETTER RESPONSE TO BORTEZOMIB-CONTAINING IMMUNOCHEMOTHERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA

• Adrian Mosquera-Orgueira,
• Jose Angel Diaz Arias,
• Rocio Serrano Martin,
• Victor Portela Piñeiro,
• Miguel Cid Lopez,
• Andres Peleteiro Raindo,
• Laura Bao Perez,
• Marta Sonia Gonzalez Perez,
• Manuel Mateo Perez Encinas,
• Maximo Francisco Fraga Rodriguez,
• Juan Carlos Vallejo Llamas,
• Jose Luis Bello Lopez

Affiliations

Adrian Mosquera-Orgueira

1 University Hospital of Santiago de Compostela, Hematology, Santiago de Compostela, Spain

Jose Angel Diaz Arias

1 University Hospital of Santiago de Compostela, Hematology, Santiago de Compostela, Spain

Rocio Serrano Martin

1 University Hospital of Santiago de Compostela, Hematology, Santiago de Compostela, Spain

Victor Portela Piñeiro

1 University Hospital of Santiago de Compostela, Hematology, Santiago de Compostela, Spain

Miguel Cid Lopez

1 University Hospital of Santiago de Compostela, Hematology, Santiago de Compostela, Spain

Andres Peleteiro Raindo

1 University Hospital of Santiago de Compostela, Hematology, Santiago de Compostela, Spain

Laura Bao Perez

1 University Hospital of Santiago de Compostela, Hematology, Santiago de Compostela, Spain

Marta Sonia Gonzalez Perez

1 University Hospital of Santiago de Compostela, Hematology, Santiago de Compostela, Spain

Manuel Mateo Perez Encinas

1 University Hospital of Santiago de Compostela, Hematology, Santiago de Compostela, Spain

Maximo Francisco Fraga Rodriguez

1 University Hospital of Santiago de Compostela, Hematology, Santiago de Compostela, Spain

Juan Carlos Vallejo Llamas

1 University Hospital of Santiago de Compostela, Hematology, Santiago de Compostela, Spain

Jose Luis Bello Lopez

1 University Hospital of Santiago de Compostela, Hematology, Santiago de Compostela, Spain